Clinical trial

IVIg for Demyelination in Diabetes Mellitus

NCT02372149

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-02-01

PhasePHASE4

Study timeline

Study start (unknown)2015-02-01Date precision: month

Registry last updated2016-11-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Peripheral Neuropathyunresolved

Diabetes Mellitusunresolved

Chronic Inflammatory Demyelinating Polyneuropathyunresolved

Interventions

10% intravenous immunoglobulin (IVIg)DRUG

0.9% sodium chlorideDRUG

Sponsors & collaborators

University of Torontolead sponsor

University Health Network, Torontocollaborator

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02372149 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.